How do you get from a Parkinson's risk variant to an actual drug target? Dr Sophie Farrow's DEMON Network webinar uses chromatin interactions to map genetic risk to genes, cell type by cell type. Recording now up:
www.dementiaresearcher.nihr.ac.uk/demon-webina...
Dr Sophie Farrow's DEMON Network talk on using chromatin interactions to find cell-specific drug targets in Parkinson's disease. Watch the full session now.
